Insight Venture Partners Files Intent to Sell $58.6M in Hinge Health Stock
HNGE has more than doubled off its 52-week low of $30.08 on elevated volume (2.6× avg).
Summary
A major institutional investor, Insight Venture Partners, plans to sell $58.6 million in Hinge Health stock, adding to recent insider sales as the company's shares trade near 52-week highs.
Key Events · Ownership and Investor Activity · HNGE
-
Significant Proposed Stock Sale
Insight Venture Partners, a 10% stockholder, has filed an intent to sell 732,444 shares of Class A Common stock, valued at approximately $58.6 million.
-
Ongoing Insider Distribution
This proposed sale follows previous sales by Insight Venture Partners totaling $52.2 million over the past three months, contributing to a net insider distribution of nearly $97.5 million in the last 90 days.
-
Sale Under 10b5-1 Plan
The intent to sell is part of a pre-planned 10b5-1 trading plan adopted on August 20, 2025, indicating a scheduled liquidation rather than an immediate reaction to market conditions.
-
Trading Near 52-Week Highs
The filing occurs while Hinge Health's stock is trading near its 52-week high, suggesting the institutional investor is locking in gains.
Analysis · HNGE · Technology
Insight Venture Partners, a 10% institutional stockholder, has filed an intent to sell approximately $58.6 million worth of Hinge Health Class A Common stock. This proposed sale is part of a pre-planned 10b5-1 trading plan established in August 2025. This follows recent sales by the same entity totaling $52.2 million over the past three months, contributing to a broader pattern of insider distribution while the stock trades near its 52-week high.
At the time of this filing, HNGE was trading at $81.00 on NYSE in the Technology sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $30.08 to $84.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.